Product NDC: | 54868-4515 |
Proprietary Name: | Pentoxifylline |
Non Proprietary Name: | Pentoxifylline |
Active Ingredient(s): | 400 mg/1 & nbsp; Pentoxifylline |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-4515 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075028 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030325 |
Package NDC: | 54868-4515-2 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54868-4515-2) |
NDC Code | 54868-4515-2 |
Proprietary Name | Pentoxifylline |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54868-4515-2) |
Product NDC | 54868-4515 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pentoxifylline |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20030325 |
Marketing Category Name | ANDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | PENTOXIFYLLINE |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |